Wuhan Thalys Med Tech Co Ltd (603716) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Wuhan Thalys Med Tech Co Ltd (603716) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥54.57 Million ≈ $7.99 Million USD) by net assets (CN¥1.05 Billion ≈ $154.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603716 company net worth for the company's overall valuation and market capitalisation.

Wuhan Thalys Med Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Wuhan Thalys Med Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wuhan Thalys Med Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Thalys Med Tech Co Ltd ranked by their cash flow conversion efficiency. Explore Wuhan Thalys Med Tech Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hongsheng Heat Exchanger Mnfg SHG:603090	0.047x
Zhejiang Huada New Materials Co Ltd SHG:605158	0.025x
Limbach Holdings Inc NASDAQ:LMB	0.092x
Ningbo Solartron Technology Co Ltd SHG:688299	0.028x
AmRest Holdings SE MC:EAT	0.278x
Sawit Sumbermas Sarana Tbk JK:SSMS	-0.225x
Bar Harbor Bankshares Inc NYSE MKT:BHB	0.009x
Yanpai Filtration Technology Co.Ltd. SHE:301081	N/A

Annual Cash Flow Conversion Efficiency for Wuhan Thalys Med Tech Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Thalys Med Tech Co Ltd from 2011 to 2025. View Wuhan Thalys Med Tech Co Ltd (603716) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥904.49 Million ≈ $132.35 Million	CN¥-37.75 Million ≈ $-5.52 Million	-0.042x	-140.32%
2024-12-31	CN¥962.04 Million ≈ $140.78 Million	CN¥99.60 Million ≈ $14.57 Million	0.104x	+8.12%
2023-12-31	CN¥1.31 Billion ≈ $192.38 Million	CN¥125.89 Million ≈ $18.42 Million	0.096x	+409.71%
2022-12-31	CN¥1.50 Billion ≈ $219.05 Million	CN¥28.12 Million ≈ $4.12 Million	0.019x	+124.52%
2021-12-31	CN¥1.74 Billion ≈ $255.04 Million	CN¥-133.52 Million ≈ $-19.54 Million	-0.077x	-1488.68%
2020-12-31	CN¥1.80 Billion ≈ $263.77 Million	CN¥9.94 Million ≈ $1.46 Million	0.006x	-90.48%
2019-12-31	CN¥1.62 Billion ≈ $237.21 Million	CN¥93.92 Million ≈ $13.74 Million	0.058x	+247.56%
2018-12-31	CN¥1.63 Billion ≈ $237.88 Million	CN¥-63.83 Million ≈ $-9.34 Million	-0.039x	+37.69%
2017-12-31	CN¥1.00 Billion ≈ $146.88 Million	CN¥-63.25 Million ≈ $-9.26 Million	-0.063x	-218.21%
2016-12-31	CN¥859.29 Million ≈ $125.74 Million	CN¥-17.02 Million ≈ $-2.49 Million	-0.020x	-120.20%
2015-12-31	CN¥470.30 Million ≈ $68.82 Million	CN¥46.11 Million ≈ $6.75 Million	0.098x	+32.39%
2014-12-31	CN¥405.99 Million ≈ $59.41 Million	CN¥30.07 Million ≈ $4.40 Million	0.074x	-21.25%
2013-12-31	CN¥345.97 Million ≈ $50.63 Million	CN¥32.54 Million ≈ $4.76 Million	0.094x	+933.02%
2012-12-31	CN¥296.50 Million ≈ $43.39 Million	CN¥2.70 Million ≈ $394.98K	0.009x	+109.55%
2011-12-31	CN¥253.90 Million ≈ $37.15 Million	CN¥-24.22 Million ≈ $-3.54 Million	-0.095x	--

About Wuhan Thalys Med Tech Co Ltd

SHG:603716 China Diagnostics & Research

Market Cap

$580.52 Million

CN¥3.97 Billion CNY

Market Cap Rank

#11652 Global

#3349 in China

Share Price

CN¥17.57

Change (1 day)

+3.96%

52-Week Range

CN¥13.40 - CN¥29.09

All Time High

CN¥45.48